Creative Planning
IART icon

Creative Planning’s Integra LifeSciences IART Stock Holding History

Creative Planning’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
98,772
+31,056
+46% +$434K ﹤0.01% 2186
2026
Q1 		$638K Buy
67,716
+28,645
+73% +$314K ﹤0.01% 2834
2025
Q4 		$485K Buy
39,071
+2,727
+8% +$36.3K ﹤0.01% 2872
2025
Q3 		$521K Buy
36,344
+20,221
+125% +$277K ﹤0.01% 2683
2025
Q2 		$198K Sell
16,123
-1,129
-7% -$16.4K ﹤0.01% 3227
2025
Q1 		$379K Sell
17,252
-1,247
-7% -$29.3K ﹤0.01% 2550
2024
Q4 		$420K Buy
+18,499
New +$404K ﹤0.01% 2390
2023
Q4 		– Sell
-105
Closed -$4.01K – 2913
2023
Q3 		$4.01K Buy
+105
New +$4.42K ﹤0.01% 2745
2017
Q3 		– Sell
-10
Closed -$1K – 2724
2017
Q2 		$1K Buy
+10
New +$478 ﹤0.01% 4445
2013
Q3 		– Sell
-489
Closed -$7K – 3273
2013
Q2 		$7K Buy
+489
New +$7.17K ﹤0.01% 2414

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Creative Planning's IART Position: Q2 2026 in Review

Creative Planning increased its Integra LifeSciences (IART) stake by 46% in Q2 2026, buying an estimated $434K and bringing the position to 98,772 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Creative Planning first reported a position in IART in Q2 2013 and has held it in 10 quarters since. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Creative Planning held 98,772 shares of Integra LifeSciences worth $1.77M as of Q2 2026.
  • Creative Planning bought 31,056 Integra LifeSciences shares in Q2 2026, an estimated $434K.
  • Integra LifeSciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2186 holding.
  • Creative Planning first reported a position in Integra LifeSciences in Q2 2013 and has held it in 10 quarters since.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.